Vitexin Research

Updated: May 7

Research has demonstrated that the flavonoid vitexin possesses anti-inflammatory and neuroprotective properties that could result in it being of value in the treatment of diabetes, obesity, osteoarthritis, and epilepsy.

Copyright © Higher Learning LV™


A 2019 study entitled "Vitexin Alleviates Non-alcoholic Fatty Liver Disease" that was published in the journal Biochemical and Biophysical Research Communications noted that "non-alcoholic fatty liver disease (NAFLD) is a most common liver disorder characterized by accumulation of fat in the liver" and that obesity and diabetes commonly result from the disease.


The study found that vitexin resulted in "significant reduction in body and liver weight," including reductions in "triglyceride and cholesterol content in serum and liver." The study concluded that "vitexin alleviates NAFLD."

The study found that vitexin resulted in "significant reduction in body and liver weight," including reductions in "triglyceride and cholesterol content in serum and liver." The study concluded that "vitexin alleviates NAFLD."


A 2019 study entitled "Vitexin Alleviates Interleukin-1β-induced Inflammatory Responses in Osteoarthritis Patients" that was published in the Scandanavian Journal of Immunology investigated "the anti-inflammatory effects of vitexin on IL-1β-stimulated human osteoarthritis."

The study reported that treatment with vitexin "significantly inhibited IL-1β-induced expressions of proinflammatory cytokine levels" and concluded "our study demonstrates that vitexin alleviates IL-1β-induced inflammatory responses in chondrocytes from osteoarthritis patients."


Learn More

To learn more, subscribe to the Higher Learning LV™ Knowledgebase, the largest ad-free cannabis article/video repository in the world!

38 views0 comments

Recent Posts

See All